DK2033629T3 - Fast farmaceutisk sammensætning omfattende valsartan - Google Patents

Fast farmaceutisk sammensætning omfattende valsartan

Info

Publication number: DK2033629T3
Authority: DK; Denmark
Prior art keywords: valsartan; pharmaceutical composition; solid pharmaceutical; solid; composition
Prior art date: 2004-12-24

Application number

DK08165631.6T

Other languages

English (en)

Inventor

Miha Vrbinc

Vovk Janika Slanc

Marija Rangus

Silvo Zupancic

Franci Bevec

Lidija Cernosa

Original Assignee

Krka

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-24

Filing date

2005-12-23

Publication date

2013-02-04

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35966966&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2033629(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-12-24 Priority claimed from EP04030782A external-priority patent/EP1674080A1/en

2005-12-23 Application filed by Krka filed Critical Krka

2013-02-04 Application granted granted Critical

2013-02-04 Publication of DK2033629T3 publication Critical patent/DK2033629T3/da

Links

239000004072 C09CA03 - Valsartan Substances 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
239000007787 solid Substances 0.000 title 1
SJSNUMAYCRRIOM-QFIPXVFZSA-N valsartan Chemical compound C1=CC(CN(C(=O)CCCC)[C@@H](C(C)C)C(O)=O)=CC=C1C1=CC=CC=C1C1=NN=N[N]1 SJSNUMAYCRRIOM-QFIPXVFZSA-N 0.000 title 1
229960004699 valsartan Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Cardiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Heart & Thoracic Surgery (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

DK08165631.6T 2004-12-24 2005-12-23 Fast farmaceutisk sammensætning omfattende valsartan DK2033629T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP04030782A EP1674080A1 (en)	2004-12-24	2004-12-24	Solid pharmaceutical composition comprising valsartan
EP05004433		2005-03-01
EP20050824409 EP1833464A1 (en)	2004-12-24	2005-12-23	Solid pharmaceutical composition comprising valsartan

Publications (1)

Publication Number	Publication Date
DK2033629T3 true DK2033629T3 (da)	2013-02-04

Family

ID=35966966

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK08165631.6T DK2033629T3 (da)	2004-12-24	2005-12-23	Fast farmaceutisk sammensætning omfattende valsartan

Country Status (16)

Country	Link
US (1)	US20080102120A1 (da)
EP (2)	EP2033629B1 (da)
CN (1)	CN101087589B (da)
AU (1)	AU2005318365B2 (da)
CA (1)	CA2592091A1 (da)
DK (1)	DK2033629T3 (da)
EA (2)	EA015108B1 (da)
ES (1)	ES2397552T3 (da)
HR (1)	HRP20130033T1 (da)
ME (1)	ME01453B (da)
NO (1)	NO20073889L (da)
PL (1)	PL2033629T3 (da)
PT (1)	PT2033629E (da)
RS (1)	RS52607B (da)
SI (1)	SI2033629T1 (da)
WO (1)	WO2006066961A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PE20081364A1 (es) *	2006-09-04	2008-12-04	Novartis Ag	Composicion farmaceutica que comprende valsartan
EP1897537A1 (en) *	2006-09-04	2008-03-12	Novartis AG	Composition comprising an angiotensin II receptor antagonist
US20080152717A1 (en) *	2006-12-14	2008-06-26	Isp Investments, Inc.	Amorphous valsartan and the production thereof
TR200703568A1 (tr) *	2007-05-24	2008-07-21	Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket�	Valsartan formülasyonları
GB0715628D0 (en) *	2007-08-10	2007-09-19	Generics Uk Ltd	Solid valsartan composition
WO2009113091A2 (en) *	2008-01-24	2009-09-17	Usv Limited	Pharmaceutical compositions comprising valsartan
EP2405899A2 (en) *	2009-03-11	2012-01-18	Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi	Valsartan formulations
WO2011102702A2 (en)	2010-02-16	2011-08-25	Krka, D. D., Novo Mesto	Process for the preparation of oral solid dosage forms comprising valsartan
CN102119912A (zh) *	2011-01-25	2011-07-13	南京白敬宇制药有限责任公司	一种非水溶性药物缓释制剂的制备方法
CN102204907A (zh) *	2011-03-31	2011-10-05	北京赛科药业有限责任公司	一种含缬沙坦的药物组合物及其制备方法
WO2013098576A1 (en)	2011-12-31	2013-07-04	Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi	Immediate release pharmaceutical composition of valsartan
WO2013098578A1 (en)	2011-12-31	2013-07-04	Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi	Immediate release pharmaceutical composition of valsartan hydrochlorothiazide
CN103599084B (zh) *	2013-11-22	2018-10-30	威海迪素制药有限公司	一种降压组合物
KR101545268B1 (ko)	2015-02-05	2015-08-20	보령제약 주식회사	정제 및 이의 제조방법
CN104887640B (zh) *	2015-06-30	2017-12-19	昆明医科大学	一种含有缬沙坦的固体药物组合物
US20210267908A1 (en) *	2020-03-02	2021-09-02	Mankind Pharma Ltd.	Pharmaceutical compositions of rivaroxaban
CN112098408B (zh) *	2020-09-14	2022-12-09	湖北亿纬动力有限公司	一种羧甲基纤维素钠溶解效果的检测方法及应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE122010000024I1 (de) *	1990-02-19	2010-07-08	Novartis Ag	Acylverbindungen
GB9613470D0 (en) *	1996-06-27	1996-08-28	Ciba Geigy Ag	Small solid oral dosage form
KR100646716B1 (ko)	1998-12-23	2006-11-17	노파르티스 아게	Ａｔ-1 또는 ａｔ-2 수용체의 증가와 관련된 질환의치료에 있어서 ａｔ-1 수용체 길항제 또는 ａｔ-2 수용체조절제의 용도
US6294192B1 (en) *	1999-02-26	2001-09-25	Lipocine, Inc.	Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6211217B1 (en) *	1999-03-16	2001-04-03	Novartis Ag	Method for reducing pericardial fibrosis and adhesion formation
US20030236236A1 (en) *	1999-06-30	2003-12-25	Feng-Jing Chen	Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
KR20020089437A (ko) *	2000-04-12	2002-11-29	노파르티스 아게	유기 화합물의 배합
US6499984B1 (en) *	2000-05-22	2002-12-31	Warner-Lambert Company	Continuous production of pharmaceutical granulation
CZ20024180A3 (cs)	2000-06-22	2003-04-16	Novartis Ag	Pevné orální farmaceutické kompozice obsahující valsartan
BR0112665A (pt) *	2000-07-19	2003-06-24	Novartis Ag	Sais
US20030152622A1 (en) *	2001-10-25	2003-08-14	Jenny Louie-Helm	Formulation of an erodible, gastric retentive oral diuretic
PT1467728E (pt)	2002-01-17	2007-11-14	Novartis Ag	Composições farmacêuticas compreendendo valsartan e inibidores da nep
CA2506809A1 (en) *	2002-12-18	2004-07-01	Giles Victor Campion	Combinations of valsartan with cox-2 inhibitors
EP1511739B1 (en) *	2003-03-17	2008-04-30	Teva Pharmaceutical Industries Ltd.	Polymorphs of valsartan
EP1556363A2 (en)	2003-04-21	2005-07-27	Teva Pharmaceutical Industries Limited	Process for the preparation of valsartan and intermediates thereof
US7378531B2 (en) *	2003-04-21	2008-05-27	Teva Pharmaceutical Industries Ltd	Process for the preparation of valsartan
US7569612B1 (en) *	2006-08-21	2009-08-04	Mutual Pharmaceutical Company, Inc.	Methods of use of fenofibric acid

2005
- 2005-12-23 EA EA200900646A patent/EA015108B1/ru not_active IP Right Cessation
- 2005-12-23 DK DK08165631.6T patent/DK2033629T3/da active
- 2005-12-23 US US11/794,039 patent/US20080102120A1/en not_active Abandoned
- 2005-12-23 ES ES08165631T patent/ES2397552T3/es not_active Expired - Lifetime
- 2005-12-23 AU AU2005318365A patent/AU2005318365B2/en not_active Ceased
- 2005-12-23 WO PCT/EP2005/013963 patent/WO2006066961A1/en not_active Ceased
- 2005-12-23 ME MEP-2012-149A patent/ME01453B/me unknown
- 2005-12-23 CN CN2005800447851A patent/CN101087589B/zh not_active Expired - Fee Related
- 2005-12-23 RS RS20120564A patent/RS52607B/sr unknown
- 2005-12-23 CA CA002592091A patent/CA2592091A1/en not_active Abandoned
- 2005-12-23 PL PL08165631T patent/PL2033629T3/pl unknown
- 2005-12-23 SI SI200531638T patent/SI2033629T1/sl unknown
- 2005-12-23 PT PT81656316T patent/PT2033629E/pt unknown
- 2005-12-23 EA EA200701107A patent/EA012392B1/ru not_active IP Right Cessation
- 2005-12-23 EP EP08165631A patent/EP2033629B1/en not_active Revoked
- 2005-12-23 EP EP20050824409 patent/EP1833464A1/en not_active Withdrawn
2007
- 2007-07-24 NO NO20073889A patent/NO20073889L/no not_active Application Discontinuation
2013
- 2013-01-16 HR HRP20130033TT patent/HRP20130033T1/hr unknown

Also Published As

Publication number	Publication date
SI2033629T1 (sl)	2013-01-31
EA015108B1 (ru)	2011-06-30
AU2005318365A1 (en)	2006-06-29
HRP20130033T1 (hr)	2013-02-28
AU2005318365B2 (en)	2011-02-03
ME01453B (me)	2014-04-20
ES2397552T3 (es)	2013-03-07
PL2033629T3 (pl)	2013-04-30
RS52607B (sr)	2013-04-30
EA200701107A1 (ru)	2008-04-28
EP2033629B1 (en)	2012-11-14
EA200900646A1 (ru)	2009-10-30
WO2006066961A1 (en)	2006-06-29
PT2033629E (pt)	2013-01-24
CN101087589B (zh)	2013-01-30
US20080102120A1 (en)	2008-05-01
CN101087589A (zh)	2007-12-12
CA2592091A1 (en)	2006-06-29
EP1833464A1 (en)	2007-09-19
EP2033629A1 (en)	2009-03-11
NO20073889L (no)	2007-09-24
EA012392B1 (ru)	2009-10-30

Publication	Publication Date	Title
BRPI0511900A (pt)	2008-01-22	composições farmacêuticas
HUS1400051I1 (hu)	2016-10-28	Lurazidont tartalmazó gyógyászati készítmény
DK1940467T3 (da)	2017-02-13	Lægemiddelsammensætning med langvarig frigivelse
EP1788047A4 (en)	2011-12-21	WATER REPELLENT / OIL-REPELLING COMPOSITION
NO20075628L (no)	2007-11-05	Farmasøytiske formuleringer
DK1587478T3 (da)	2013-10-21	Farmaceutisk sammensætning
IL177480A0 (en)	2006-12-10	Pharmaceutical composition
DK1725218T3 (da)	2014-09-01	Farmaceutisk sammensætning omfattende pimobendan
SK4325U (sk)	2005-12-01	Farmaceutická kompozícia s postupným uvoľňovaním
DK1957073T3 (da)	2014-05-12	Lægemiddel
ZA200705131B (en)	2008-06-25	Solid pharmaceutical composition comprising valsartan
SI2033629T1 (sl)	2013-01-31	Trden farmacevtski sestavek, ki obsega valsartan
DE602005017191D1 (de)	2009-11-26	Geruchsreduzierte waschstück-zusammensetzung
HU0401177D0 (en)	2004-08-30	Pharmaceutical composition
GB2411355B (en)	2006-02-22	Pharmaceutical composition
FR2871686B1 (fr)	2008-02-29	Composition anti-decoloration
ITMI20041447A1 (it)	2004-10-20	Composizione farmaceutica comprendente gabapentina
GB0425255D0 (en)	2004-12-15	Pharmaceutical composition
ZA200701932B (en)	2008-08-27	Pharmaceutical composition
BRPI0614413A2 (pt)	2016-11-22	composto, e, composição farmacêutica
BRPI0614412A2 (pt)	2016-11-22	composto, e, composição farmacêutica
NO20055101D0 (no)	2005-11-01	Sot-rensemiddel
ITMI20040943A1 (it)	2004-08-11	Composizione farmaceutica cicatrizzante
ZA200701931B (en)	2008-10-29	Pharmaceutical composition
EP1845944A4 (en)	2011-07-27	PHARMACEUTICAL COMPOSITIONS